Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple coagulation factor deficiencies (MCFDs) are rare inherited bleeding disorders characterized by the simultaneous deficiency or dysfunction of two or more blood coagulation factors. These factors are essential proteins involved in the coagulation cascade, which leads to blood clot formation. MCFDs can arise from coincidental inheritance of single-factor deficiencies, single-gene defects affecting multiple factors, or chromosomal deletions. Diagnosis involves clotting assays and molecular genetic testing. Treatment typically involves replacement therapy with plasma-derived or recombinant coagulation factors.
Replacement of deficient coagulation factors, modulation of coagulation pathways (indirectly)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Coagulation Factor Deficiencies (MCFDs).